cyclohexanol has been researched along with paliperidone palmitate in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Albano, D; Amchin, J; Klockowski, PM; Taylor, KP; Zarycranski, W | 1 |
| Liang, CS; Yang, FW | 1 |
| Bearman, P; Essick, C; King, M; Ross, JS | 1 |
| Eliasson, E; Haslemo, T; Lindh, JD; Mannheimer, B; Molden, E | 1 |
4 other study(ies) available for cyclohexanol and paliperidone palmitate
| Article | Year |
|---|---|
Effect of venlafaxine on the pharmacokinetics of risperidone.
Topics: Adult; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Anxiety; Area Under Curve; Cyclohexanols; Desvenlafaxine Succinate; Exploratory Behavior; Female; Humans; Isoxazoles; Male; Metabolic Clearance Rate; Middle Aged; Paliperidone Palmitate; Psychomotor Performance; Pyrimidines; Risperidone; Venlafaxine Hydrochloride | 1999 |
Paliperidone augmentation for treatment-resistant depression: a case report.
Topics: Cyclohexanols; Depressive Disorder, Major; Drug Resistance; Drug Therapy, Combination; Female; Humans; Isoxazoles; Middle Aged; Paliperidone Palmitate; Pyrimidines; Treatment Outcome; Venlafaxine Hydrochloride | 2011 |
Medical school gift restriction policies and physician prescribing of newly marketed psychotropic medications: difference-in-differences analysis.
Topics: Antidepressive Agents; Antipsychotic Agents; Case-Control Studies; Central Nervous System Stimulants; Cyclohexanols; Desvenlafaxine Succinate; Dextroamphetamine; Drug Industry; Gift Giving; Health Care Sector; Humans; Interprofessional Relations; Isoxazoles; Marketing of Health Services; Organizational Policy; Paliperidone Palmitate; Practice Patterns, Physicians'; Psychotropic Drugs; Pyrimidines; Schools, Medical; United States | 2013 |
Risperidone and Venlafaxine Metabolic Ratios Strongly Predict a CYP2D6 Poor Metabolizing Genotype.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Child; Cyclohexanols; Cytochrome P-450 CYP2D6; Desvenlafaxine Succinate; Female; Genotype; Humans; Male; Middle Aged; Paliperidone Palmitate; Predictive Value of Tests; Retrospective Studies; Risperidone; Sensitivity and Specificity; Venlafaxine Hydrochloride; Young Adult | 2016 |